Adjunctive therapies in sepsis: An evidence-based review

Critical Care Medicine

Volumn 32, Issue 11 SUPPL., 2004, Pages

  Cariou, Alain ^a   Vinsonneau, Christophe ^a   Dhainaut, Jean François ^a  

^a University of Paris 5 ^*  (France)

Author keywords

[No Author keywords available]

Indexed keywords

BICARBONATE; CARBICARB; DICHLOROACETIC ACID; GLUCOSE; INSULIN; TROMETAMOL;

ACUTE KIDNEY FAILURE; ADD ON THERAPY; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DIABETES CONTROL; DIALYSIS; DISEASE COURSE; DISEASE SEVERITY; ENTERIC FEEDING; EVIDENCE BASED MEDICINE; FLUID BALANCE; GLUCOSE BLOOD LEVEL; HEMODIALYSIS; HEMODYNAMICS; HEMOFILTRATION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; HYPOGLYCEMIA; KIDNEY TRANSPLANTATION; LACTIC ACIDEMIA; LIVER NECROSIS; MEDICAL LITERATURE; PARENTERAL NUTRITION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUESTIONNAIRE; REVIEW; SEPSIS; SIDE EFFECT; SURVIVAL RATE; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

ACIDOSIS; BLOOD GLUCOSE; CONSENSUS DEVELOPMENT CONFERENCES; EVIDENCE-BASED MEDICINE; HEMOFILTRATION; HUMANS; KIDNEY FAILURE, CHRONIC; PRACTICE GUIDELINES; RENAL DIALYSIS; SEPSIS;

EID: 8444230448     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000142910.01076.A5     Document Type: Review

References (95)

1. Vincent JL, Abraham E, Annane D, et al: Reducing mortality in sepsis: New directions. Crit Care 2002; 6:S1-S18
2. Van den Berghe G, Wouters P, Weekers F, et al: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001; 345:1359-1367
3. Van den Berghe G, Wouters PJ, Bouillon R, et al: Outcome benefit of intensive insulin therapy in the critically ill: Insulin dose versus glycemic control. Crit Care Med 2003; 31:359-366
4. Fath-Ordoubadi F, Beatt KJ: Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: An overview of randomized placebo-controlled trials. Circulation 1997; 96:1152-1156
5. Annane D, Melchior JC: Hormone replacement therapy for the critically ill. Crit Care Med 2003; 31:634-635
6. Evans TW: Hemodynamic and metabolic therapy in critically ill patients. N Engl J Med 2001; 345:1417-1418
7. Satomi N, Sakurai A, Haranaka K: Relationship of hypoglycemia to tumor necrosis factor production and antitumor activity: Role of glucose, insulin, and macrophages. J Natl Cancer Inst 1985; 74:1255-1260
8. Das UN: Is insulin an antiinflammatory molecule? Nutrition 2001; 17:409-413
9. Hansen TK, Thiel S, Wouters PJ, et al: Intensive insulin therapy exerts antiinflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab 2003; 88:1082-1088
10. Carr ME: Diabetes mellitus: A hypercoagulable state. J Diabetes Complications 2001; 15:44-54
11. Dandona P, Aljada A, Mohanty P, et al: Insulin inhibits intranuclear nuclear factor kappaB and stimulates IkappaB in mononuclear cells in obese subjects: Evidence for an anti-inflammatory effect? J Clin Endocrinol Metab 2001; 86:3257-3265
12. Kwoun MO, Ling PR, Lydon E, et al: Immunologic effects of acute hyperglycemia in nondiabetic rats. JPEN J Parenter Enteral Nutr 1997; 21:91-95
13. Klein S, Kinney J, Jeejeebhoy K, et al: Nutrition support in clinical practice: Review of published data and recommendations for future research directions. Summary of a conference sponsored by the National Institutes of Health, American Society for Parenteral and Enteral Nutrition, and American Society for Clinical Nutrition. Am J Clin Nutr 1997; 66:683-706
14. Groeneveld ABJ, Tran DD, van der Meulen J, et al: Acute renal failure in the medical intensive care unit: Predisposing, complicating factors and outcome. Nephron 1991; 59:602-610
15. Brivet FG, Kleinknecht DJ, Loirat P, et al: Acute renal failure in intensive care unit: Causes, outcome and prognostic factor of hospital mortality. A prospective, multicenter study. Crit Care Med 1996; 24:192-198
16. Hoste EAJ, Lameire NH, Vanholder RC, et al: Acute renal failure in patients with sepsis in a surgical ICU: Predictive factors, incidence, comorbidity, and outcome. J Am Soc Nephrol 2003; 14:1022-1030
17. Schaeffer JH, Jochimsen F, Keller F, et al: Outcome prediction of acute renal failure in medical intensive care. Intensive Care Med 1991; 17:19-24
18. Metnitz PGH, Krenn CG, Steltzer H, et al: Effect of acute renal failure requiring renal replacement therapy on outcome in critically ill patients. Crit Care Med 2002; 30:2051-2058
19. Rouby JJ, Rottembourg J, Durande J, et al: Hemodynamic change induced by regular hemodialysis and sequential ultrafiltration hemodialysis: A comparative study. Kidney Int 1980; 17:801-810
20. Hoffmann JN, Hartl WH, Deppisch R, et al: Effect of hemofiltration on hemodynamics and systemic concentrations of anaphylatoxins and cytokines in human sepsis. Intensive Care Med 1996; 22:1360-1367
21. Bellomo R, Ronco C: Continuous renal replacement therapy in intensive care unit. Intensive Care Med 1999; 25:781-789
22. Schiffl H, Lang S, Fischer R: Daily hemodialysis and the outcome of acute renal failure. N Engl J Med 2002; 346:306-310
23. Brazen JM, Ingelfinger JR, Curfman GD: Removal of expression of concern: Schiffl et al., "Daily Hemodialysis and the Outcome of Acute Renal Failure." N Engl J Med 2003; 349:1965
24. Ronco C, Bellomo R, Homal P, et al: Effects of different dose in continuous veno-venous haemofiltration on outcomes of acute renal failure: A prospective randomised trial. Lancet 2000; 356:26-30
25. Eknoyan G, Levin N: NKF-K/DOQI clinical practice guidelines updates 2000: Foreword. Am J Kidney Dis 2001; 37(Suppl):S5-S238
26. Kleinknecht D, Jungers P, Chanard J, et al: Uremic and non-uremic complications in acute renal failure: Evaluation of early and frequent dialysis on prognosis. Kidney Int 1972; 1:190-196
27. Conger J: A controlled evaluation of prophylactic dialysis in post traumatic acute renal failure. J Trauma 1975; 15:1056-1063
28. Paganini EP, Tapolyai M, Goormastic M, et al: Establishing a dialysis therapy/patient outcome link in intensive care unit dialysis for patients with acute renal failure. Am J Kidney Dis 1996; 28:S81-S89
29. Bonventre JV: Daily hemodialysis: Will treatment each day improve the outcome in patients with acute renal failure? N Engl J Med 2002; 346:362-363
30. Bouman CSC, Oudemans-van Straaten HM, Tijssen JCP, et al: Effects of early high volume continuous venovenous hemofiltration on survival and recovery of renal function in intensive care patients with acute renal failure: A prospective randomized trial. Crit Care Med 2002; 30:2205-2211
31. Ronco C, Bellomo R: Acute renal failure and multiple organ dysfunction in the ICU: From renal replacement therapy (RRT) to multiple organ support therapy (MOST). Int J Artif Organs 2002; 25:733-747
32. Mauritz W, Sporn P, Schindler I, et al: Acute renal failure in abdominal infection: Comparison of hemodialysis and continuous arteriovenous and continuous hemofiltration. Anasth Intensivther Nortfallmed 1986; 21:212-217
33. Bartlett RH, Mault JR, Dechert RE, et al: Continuous arterio-venous hemofiltration: Improved survival in surgical acute renal failure? Surgery 1986; 100:400-408
34. Kierdorf H: Continuous versus intermittent treatment: Clinical results in acute renal failure. Contrib Nephrol 1991; 93:1-12
35. Bellomo R, Mansfield D, Rumble S, et al: Acute renal failure in critical illness: Conventional dialysis versus continuous hemodiafiltration. Am Soc Artif Intern Organs J 1992; 38:M654-M657
36. Bellomo R, Farmer M, Parkin G, et al: Severe acute renal failure: A comparison of acute continuous hemodiafiltration and conventional dialytic therapy. Nephron 1995; 71:59-64
37. Kruczinski K, Irvine-Bird K, Toffelmire EB, et al: A comparison of continuous arteriovenous hemofiltration and intermittent hemodialysis in acute renal failure patients in intensive care unit. Am Soc Artif Intern Organs J 1993; 38:M778-M781
38. Van Bommel EH, Bouvy ND, Sob KL, et al: Acute dialytic support for the critically ill: Intermittent hemodialysis versus continuous arteriovenous hemodiafiltration. Am J Nephrol 1995; 15:192-200
39. Mehta RL, Mc Donald B, Gabbai FB, et al: A randomized clinical trial of continuous versus intermittent dialysis for acute renal failure. Kidney Int 2001; 60:1154-1163
40. Guerin C, Girard R, Selli JM, et al: Intermittent versus continuous renal replacement therapy for acute renal failure in intensive care units: Results from a multicenter prospective epidemiological survey. Intensive Care Med 2002; 28:1411-1418
41. Kellum J, Angus DC, Johnson JP, et al: Continuous versus intermittent renal replacement therapy: A meta-analysis. Intensive Care Med 2002; 28:29-37
42. Kellum J, Mehta RL, Angus DC, et al: The first international consensus conference on continuous renal replacement therapy: The ADQI Workgroup. Kidney Int 2002; 62:1855-1863
43. Grootendorst AF, Van Bommel EFH, Van der Hoven B, et al: High volume hemofiltration improves hemodynamics of endotoxin-induced shock in the pig. J Crit Care 1992; 7:67-75
44. Rogiers P, Zhang H, Smail N, et al: Continuous venovenous hemofiltration improves cardiac performance by mechanism other than tumor necrosis factor-α attenuating during endotoxic shock. Crit Care Med 1999; 27:1848-1855
45. Bellomo R, Kellum JA, Chandrashekhar RG, et al: The effect of intensive plasma water exchange by hemofiltration on hemodynamics and soluble mediators in canine endotoxemia. Am J Respir Crit Care Med 2000; 161:1429-1436
46. Cole L, Bellomo R, Journois D, et al: High volume haemofiltration in human septic shock. Intensive Care Med 2001; 27:978-986
47. Honore PM, Jamez J, Wauthier M, et al: Prospective evaluation of short term, high volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000; 28:3581-3587
48. Mink SN, Li X, Bose D, et al: Early but not delayed continuous arteriovenous hemofiltration improves cardiovascular function in sepsis in dogs. Intensive Care Med 1999; 25:733-743
49. Yekebas EF, Strate T, Zolmajd S, et al: Impact of different modalities of continuous venovenous hemofiltration on sepsis-induced alterations in experimental pancreatitis. Kidney Int 2002; 62:1806-1818
50. Cole L, Bellomo R, Hart G, et al: A phase II randomized controlled trial of continuous hemofiltration in sepsis. Crit Care Med 2002; 30:100-106
51. Weil MH, Afifi AA: Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock). Circulation 1970; 41:989-1001
52. Stacpoole PW, Wright EC, Baumgartner TG, et al: Natural history and course of acquired lactic acidosis in adults. Am J Med 1994; 97:47-54
53. Cohen RD, Woods HF: Clinical and Biochemical Aspects of Lactic Acidosis. Boston, Blackwell Scientific Publications, 1976
54. Rivers E, Nguyen B, Havstad S, et al: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001; 345:1368-1377
55. Duke T: Dysoxia and lactate. Arch Dis Child 1999; 81:343-350
56. Levraut J, Ciebiera JP, Chave S, et al: Mild hyperlactatemia in stable septic patients is due to impaired lactate clearance rather than overproduction. Am Rev Respir Dis 1998; 157:1021-1026
57. Vary TC, Siegel JH, Nakatani T, et al: Effects of sepsis on activity of pyruvate dehydrogenase complex in skeletal muscle and liver. Am J Physiol 1986; 250:E634-E640
58. Forsythe SM, Schmidt GA: Sodium bicarbonate for the treatment of lactic acidosis. Chest 2000; 117:260-267
59. Adrogue HJ, Madias NE: Management of life-threatening acid-base disorders: First of two parts. N Engl J Med 1998; 338:26-34
60. Kraut JA, Kurtz I: Use of base in the treatment of severe acidemic states. Am J Kidney Dis 2001; 38:703-727
61. 3 in experimental lactic acidosis in dogs. Am J Physiol 1982; 242:F586-F591
62. Graf H, Leach W, Arieff AI: Metabolic effects of sodium bicarbonate in hypoxic lactic acidosis in dogs. Am J Physiol 1985; 249:F630-F635
63. Bonventre JV, Cheung JY: Effects of metabolic acidosis on viability of cells exposed to anoxia. Am J Physiol 1985; 249:C149-C159
64. Roos A, Boron WP: Intracellular pH. Physiol Rev 1981; 61:296-334
65. Levitsky J, Gurell D, Frishman WH: Sodium ion/hydrogen ion exchange inhibition: A new pharmacologic approach to myocardial ischemia and reperfusion injury. J Clin Pharmacol 1998; 38:887-897
66. Hindman BJ: Sodium bicarbonate in the treatment of subtypes of acute lactic acidosis: Physiologic considerations. Anesthesiology 1990; 72:1064-1076
67. Poole-Wilson PA, Langer GA: Effect of pH on ionic exchange and function in rat and rabbit myocardium. Am J Physiol 1975; 229:570-581
68. Preckel B, Schlack W, Obal D, et al: Effect of acidotic blood reperfusion on reperfusion injury after coronary artery occlusion in the dog heart. J Cardiovasc Pharmacol 1998; 31:179-186
69. Kitakaze M, Takashima S, Funaya H, et al: Temporary acidosis during reperfusion limits myocardial infarct size in dogs. Am J Physiol 1997; 272:H2071-H2078
70. Shapiro JI: Functional and metabolic responses of isolated hearts to acidosis: Effects of sodium bicarbonate and Carbicarb. Am J Physiol 1990; 258:H1835-H1839
71. Nakanishi T, Okuda H, Kamata K, et al: Influence of acidosis on inotropic effect of catecholamines in newborn rabbit hearts. Am J Physiol 1987; 253:H1441-H1448
72. Orchard CH, Kentish JC: Effects of pH change on the contractile function of cardiac muscle. Am J Physiol 1990; 258:C967-C981
73. Downing SE, Talner NS, Gardner TH: Cardiovascular responses to metabolic acidosis. Am J Physiol 1965; 208:237-242
74. Cooper DJ, Herbertson MJ, Werner HA, et al: Bicarbonate does not increase left ventricular contractility during L-lactic acidemia in pigs. Am Rev Respir Dis 1993; 148:317-322
75. Wildenthal K, Mierzwiak DS, Myers RW, et al: Effects of acute lactic acidosis on left ventricular performance. Am J Physiol 1968; 214:1352-1359
76. Marsh JD, Margolis TI, Kim D: Mechanism of diminished contractile response to catecholamines during acidosis. Am J Physiol 1988; 254:H20-H27
77. Kiely DG, Cargill RI, Lipworth BJ: Effects of hypercapnia on hemodynamic, inotropic, lusitropic, and electrophysiologic indices in humans. Chest 1996; 109:1215-1221
78. Yatani A, Fujino T, Kinoshita K, et al: Excess lactate modulates ionic currents and tension components in frog atrial muscle. J Mol Cell Cardiol 1981; 13:147-161
79. Adrogué HJ, Chap Z, Okuda Y, et al: Acidosis-induced glucose intolerance is not prevented by adrenergic blockade. Am J Physiol 1988; 255:E812-E823
80. Adrogué HJ, Madias NE: Changes in plasma potassium concentration during acute acid-base disturbances. Am J Med 1981; 71:456-467
81. Marik PE, Varon J: The hemodynamic derangements in sepsis. Chest 1998; 114:854-860
82. Sirieix D, DeLayance S, Paris M, et al: Trishydroxymethyl aminomethane and sodium bicarbonate to buffer metabolic acidosis in an isolated heart model. Am J Respir Crit Care Med 1997; 155:957-963
83. Adrogué HJ, Rashad MN, Gorin AB, et al: Assessing acid-base status in circulatory failure: Differences between arterial and central venous blood. N Engl J Med 1989; 320:1312-1316
84. Rhee KH, Toro LO, McDonald GG, et al: Carbicarb, sodium bicarbonate, and sodium chloride in hypoxic lactic acidosis: Effect on arterial blood gases, lactate concentrations, hemodynamic variables, and myocardial intracellular pH. Chest 1993; 104:913-918
85. Cooper DJ, Herbertson MJ, Werner HA, et al: Bicarbonate does not increase left ventricular contractility during L-lactic acidemia in pigs. Am Rev Respir Dis 1993; 148:317-322
86. Cooper DJ, Walley KR, Wiggs BR, et al: Bicarbonate does not improve hemodynamics in critically ill patients who have lactic acidosis: A prospective, controlled clinical study. Ann Intern Med 1990; 112:492-498
87. Mathieu D, Neviere R, Billard V, et al: Effects of bicarbonate therapy on hemodynamics and tissue oxygenation in patients with lactic acidosis: A prospective, controlled clinical study. Crit Care Med 1991; 19:1352-1356
88. Bellingham AJ, Detter JC, Lenfant C: Regulatory mechanisms of hemoglobin oxygen affinity in acidosis and alkalosis. J Clin Invest 1971; 50:700-706
89. Bersin RM, Chatterjee K, Arieff AI: Metabolic and hemodynamic consequences of sodium bicarbonate administration in patients with heart disease. Am J Med 1989; 87:7-14
90. Bersin RM, Arieff AI: Improved hemodynamic function during hypoxia with Carbicarb, a new agent for the management of acidosis. Circulation 1998; 77:227-233
91. Park R, Arieff AI: Treatment of lactic acidosis with dichloroacetate in dogs. J Clin Invest 1982; 70:853-862
92. Stacpoole PW, Lorenz AC, Thomas RG, et al: Dichloroacetate in the treatment of lactic acidosis. Ann Intern Med 1988; 108:58-63
93. Stacpoole PW, Wright EC, Baumgartner TG, et al: A controlled clinical trial of dichloroacetate for treatment of lactic acidosis in adults. N Engl J Med 1992; 327:1564-1569
94. Hilton PJ, Taylor J, Forni LG, et al: Bicarbonate-based haemofiltration in the management of acute renal failure with lactic acidosis. Q J Med 1998; 91:279-283
95. Levraut J, Ciebiera JP, Jambou P, et al: Effect of continuous venovenous hemofiltration with dialysis on lactate clearance in critically ill patients. Crit Care Med 1997; 25:58-62